ACRI & CBHI Research Team
Server Bozdogan (Genetics, MD, Ph.D.) - Director of ACRI
Paul Lee (Chemistry, Ph.D.) - Director of CBH
Martin Chun (Material, Ph.D.)
O.S. Lee (Foods Science, Ph.D.)
ACRI Director’s Introduction
Thank you for your interest in the Advanced Calcium Research Institute (ACRI).
Our primary objective is to shed light on the role of calcium in various diseases beyond its established association with osteoporosis. In addition, recent discoveries have provided new insights into the multifaceted involvement of calcium in numerous other medical conditions, such as cancers, and neurodegenerative diseases.
With our unique positioning, ACRI can potentially impact alternative medications significantly. Leveraging our existing strengths and harnessing the potential of our innovative AIC formulation biotechnology, we collaborate with local, national, and global affiliations to bridge the gap between discoveries and develop superior treatment options.
We trust that you will find the ACRI website both captivating and enlightening. We invite you to explore our website for deeper insights into our work. Please feel free to delve into the ACRI website further into our work.
Dr. Server Bozdogan, Ph.D., Molecular Geneticist
Director of ACRI
Edward Lee (Materials Eng. Ph.D.)
James Lee (Toxicology, Ph.D.)
W.S. Kim (Material, Ph.D.)
Chris Choe (Energy, Ph.D.)
Multiple myeloma (MM) is the second most common hematological malignancy. It mostly occurs at older ages and remains an incurable disease. MM is a B cell cancer mainly characterized by the proliferation of malignant plasma cells in the bone marrow, the presence of monoclonal serum immunoglobulin, and the occurrence of osteolytic lesions. Bone remodeling effects of AIC by increasing the bone turnover rate through stimulation of osteoclast and osteoblast activity place AIC as a good candidate for novel myeloma therapy.
our Research Partners
Partnering organizations
UPCOMING CONFERENCES for 2023
Testimonials
conditions tried WITH BENEFITS
Bone & teeth health
Heart and muscle contraction
Blood clotting
Cell/DNA replication
Cellular communication
Hormone regulation
Enzyme activation
Mineralizer
Neurotransmitter
Normalizing Immune response
Healthy Cell Replication
Cell Membrane Integrity
Osteoporosis
Arthritis
Arrhythmia
Crohn’s disease
Calcium-related infertility
Bone Necrosis
Heart palpitation
Calcific tendonitis
Lyme Disease
Epilepsy
Diabetes
Alzheimer’s
Viral Infection (HIV)
ALS
Cancer (Carcinoma, Sarcoma, Lymphoma)
Parkinson’s disease
Gout
Autoimmune Disease (Lupus)
Inflammation
Mitochondrial Disease
Remarkable Recovery Under AIC
Diagnosed with Multiple Myeloma (2012)
2012 Diagnosed with Multiple Myeloma
2013 Started AIC Therapy
2015 Fully Recovered in 14 months.
Ms. Holt’s hematological data, such as platelet, WBC, and neutrophil, normalized and later declared cancer-free.
Ms. Holt’s kidney, damaged by chemo, has recovered. Also, her GFR bounced from 12 to 62, to a normal range for her age.
Ms. Holt’s BMD score also significantly improved after treatment with AIC, and she fully recovered from osteoporosis. (T score increased from -3.6 to -0.9, back to the normal bone density)
Diagnosed with cervical cancer (2012)
•Year 2012: Diagnosed with cervical cancer. Underwent radical trachelectomy
•April 2016: Recurrence of cancer.
•Nov 2016: Chemotherapy
•Jan 2017: Tumor grows back
•Feb-May 2017: Chemo and Radiation Therapy
•May 2017: Ongoing presence of cancer discovered
•May 2017: Starts AIC Therapy (AIC 3-4x /day)
•Sept 2017: Declared cancer free after TRU CUT Biopsy
•Sept 2017: Stops AIC Therapy prematurely
•Feb 2018: Recurrence of Cancer
•May-Sept 2019: Cryoablation & Ethanol Ablation in Guangzhou, China. Tumor size decreased, but cancer was still present.
•Nov 2019: Started AIC Therapy again (AIC 4x/day)
•Sept 2020: Declared cancer-free under AIC (Again) !!
•Aug 2021: After PET Scan still clinically cancer free
Diagnosed with Adenoid Cancer (2016)
“I am 51 years old and have worked as a motel manager for a long time. The stress from my work and constant heavy drinking after work took a toll on my body. Then one day, I noticed a growth inside my left cheek and had to rush to see my doctor. The test revealed that the mass was cancerous. The tumor had a diameter of 3.5 cm and was growing where nerve and blood vessels were intricately intertwined. My oncologist recommended me for surgery because radiation therapy was not deemed helpful then.
Last September 2016, I heard about AIC through my brother but decided to follow the oncologist's recommendation and surgically remove the big tumor. Many smaller tumors where surgical removal was not possible were left alone. Right after the surgery, I started to take AIC. I immediately experienced my body temperature rising and felt much stronger even after exhaustive chores from my work. I began to have both wonder and hope.
About twenty days after the surgery, the hospital called me and tried to convince me to receive 33 scheduled radiation therapy treatments. When I inquired and learned about the terrible side effects of the treatment, I could not muster the courage to go ahead with it. I decided not to take radiation therapy and rely on AIC since I was already experiencing various positive effects. Honestly, the side effects of the recommended radiotherapy, namely, dry mouth, hot flush, losing taste buds, and possible brain hemorrhage, sounded scarier than cancer itself.
Now, I am so glad I bypassed the radiation therapy and stayed with AIC. AIC removed all the traces of remaining cancer, even in the most difficult places.” (March 2017)
Book an Appointment
If you are a physician with interest in learning more about AIC therapy, please book a 25 minute free online conference at your convenient time.
Contact Us
Want to know more about AIC Therapy?
Let Us Know!
Advanced Calcium Research Institute
info@aictherapy.com